The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
A randomized trial of coenzyme Q 10 in mitochondrial disorders
Abstract
Case reports and open‐label studies suggest that coenzyme Q 10 (CoQ 10 ) treatment may have beneficial effects in mitochondrial disease patients; however, controlled trials are warranted to clinically prove its effectiveness. Thirty patients with mitochondrial cytopathy received 1200 mg/day CoQ 10 for 60 days in a randomized, double‐blind, cross‐over trial. Blood lactate, urinary markers of oxidative stress, body composition, activities of daily living, quality of life, forearm handgrip strength and oxygen desaturation, cycle exercise cardiorespiratory variables, and brain metabolites were measured. CoQ 10 treatment attenuated the rise in lactate after cycle ergometry, increased (∽1.93 ml) V O 2 /kg lean mass after 5 minutes of cycling ( P < 0.005), and decreased gray matter choline‐containing compounds ( P < 0.05). Sixty days of moderate‐ to high‐dose CoQ 10 treatment had minor effects on cycle exercise aerobic capacity and post‐exercise lactate but did not affect other clinically relevant variables such as strength or resting lactate. Muscle Nerve, 2010
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“yet there were no benefits from very high dose of coenzyme Q10 in a similar but larger cohort of patients [231]”
From Creatine monohydrate supplementation for older adults and clinical populations (2025) · cites this paper as [231]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Energy metabolism defects in Huntington's disease and effects of coenzyme Q10
Koroshetz, W. J., Jenkins, B. G., Rosen, B. R., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410206 · Cited by 405
Shults, C. W., Haas, R. H., Passov, D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410420221 · Cited by 326
Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders
Rodriguez, M. C., MacDonald, J. R., Mahoney, D. J., Parise, G., Beal, M. F., & Tarnopolsky, M. A. (2007) · Muscle & Nerve · doi:10.1002/mus.20688 · Cited by 255
Self-citationPilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease
Shults, C. W., Flint Beal, M., Song, D., & Fontaine, D. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.003 · Cited by 223
Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy
Jeppesen, T. D., Schwartz, M., Olsen, D. B., Wibrand, F., Krag, T., Duno, M., Hauerslev, S., & Vissing, J. (2006) · Brain · doi:10.1093/brain/awl149 · Cited by 211
Laaksonen, R., Jokelainen, K., Laakso, J., Sahi, T., Härkönen, M., Tikkanen, M. J., & Himberg, J.-J. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89180-1 · Cited by 171
Bendahan, D., Desnuelle, C., Vanuxem, D., Confort-Gouny, S., Figarella-Branger, D., Pellissier, J. F., Kozak-Ribbens, G., Pouget, J., Serratrice, G., & Cozzone, P. J. (1992) · Neurology · doi:10.1212/wnl.42.6.1203 · Cited by 104
The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease
Haas, R. H. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.03.008 · Cited by 92
Research works printed but not linked: 56
- 10.1097/CND.0b013e3181903126 · DOI
- Chinnery P, 2006, Treatment for mitochondrial disorders, Cochrane Database Syst Rev, CD004426
- 10.1002/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C · DOI · Paper page
- 10.1016/j.addr.2008.05.001 · DOI
- 10.1111/j.1600-0404.1991.tb03962.x · DOI
- 10.1007/BF00314013 · DOI
- 10.1212/WNL.35.3.372 · DOI
- Steele PE, 2004, Clinical laboratory monitoring of coenzyme Q10 use in neurologic and muscular diseases, Am J Clin Pathol, 121, S113
- Ferrante KL, 2005, Tolerance of high‐dose (3,000 mg/day) coenzyme Q10 in ALS, Neurology, 65, 1834, 10.1212/01.wnl.0000187070.35365.d7 · DOI · Paper page
- HSG, 2005, HDF Biennial Symposia
- 10.1002/mus.21355 · DOI
- 10.1212/WNL.39.3.399 · DOI
- 10.1111/j.1748-1716.1995.tb09988.x · DOI
- 10.1152/jappl.1996.81.1.232 · DOI · Paper page
- 10.1002/1531-8249(199910)46:4<667::AID-ANA19>3.0.CO;2-D · DOI
- 10.1002/mus.20708 · DOI
- 10.1016/S0893-133X(97)00090-0 · DOI
- 10.1007/BF02668096 · DOI · Paper page
- 10.1006/jmre.1997.1244 · DOI · Paper page
- 10.1002/mrm.1910370202 · DOI
- 10.1016/S0891-5849(99)00113-6 · DOI
- 10.1016/j.mito.2007.02.012 · DOI
- 10.1007/BF00314404 · DOI
- 10.1212/WNL.38.6.892 · DOI
- 10.1073/pnas.86.7.2379 · DOI · Paper page
- 10.1002/biof.5520250112 · DOI
- 10.1016/S0022-510X(98)00006-9 · DOI
- 10.1016/S0140-6736(00)02531-9 · DOI · Paper page
- 10.1212/WNL.56.7.849 · DOI · Paper page
- 10.1212/WNL.57.3.515 · DOI
- 10.1001/archneur.62.2.317 · DOI
- 10.1212/01.wnl.0000194241.35115.7c · DOI
- 10.1212/WNL.36.1.45 · DOI
- Laaksonen R, 1995, Serum and muscle tissue ubiquinone levels in healthy subjects, J Lab Clin Med, 125, 517
- 10.1016/j.jtcvs.2004.03.034 · DOI
- 10.1016/0022-510X(89)90112-3 · DOI
- 10.1136/jnnp.50.11.1475 · DOI
- 10.1097/01.wnf.0000137862.67131.bf · DOI
- Muller W, 1990, Coenzyme Q in opthalmoplegia plus—a double blind, cross over therapeutic trial, J Neurol Sci, 98, 442
- 10.1212/WNL.43.5.884 · DOI
- 10.1016/j.mito.2007.03.005 · DOI
- 10.1249/01.mss.0000177341.89478.06 · DOI
- 10.1023/B:NERE.0000014829.42364.dd · DOI
- 10.1111/j.1471-4159.2009.06074.x · DOI
- 10.1016/0022-510X(90)90015-F · DOI
- 10.1159/000117445 · DOI
- 10.1016/S0022-510X(98)00296-2 · DOI
- 10.1093/brain/awg028 · DOI · Paper page
- 10.1007/s004150050267 · DOI
- 10.1093/brain/awl282 · DOI · Paper page
- 10.1002/jmri.1079 · DOI
- 10.1016/j.mito.2008.05.003 · DOI
- Bianchi MC, 2003, Proton MR spectroscopy of mitochondrial diseases: analysis of brain metabolic abnormalities and their possible diagnostic relevance, AJNR Am J Neuroradiol, 24, 1958
- 10.1212/WNL.45.6.1193 · DOI
- 10.1002/mrm.1910370228 · DOI
- 10.1080/10715760290021306 · DOI
Cited by
Parikh, S., Goldstein, A., Koenig, M. K., Scaglia, F., Enns, G. M., Saneto, R., Anselm, I., Cohen, B. H., Falk, M. J., Greene, C., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.177 · Cited by 607
Self-citationMitochondrial cardiomyopathy: pathophysiology, diagnosis, and management.
(2013) · Europe PMC (PubMed Central) · Cited by 209
Review of clinical trials for mitochondrial disorders: 1997-2012
Kerr, D. S. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0176-7 · Cited by 96
Tarnopolsky, M. A. (2016) · Continuum · doi:10.1212/con.0000000000000403 · Cited by 61
Self-citationCreatine monohydrate supplementation for older adults and clinical populations
Candow, D. G., Ostojic, S. M., Chilibeck, P. D., Longobardi, I., Gualano, B., Tarnopolsky, M. A., Wallimann, T., Moriarty, T., Kreider, R. B., Forbes, S. C., et al. (2025) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2025.2534130 · Cited by 43
Self-citation
Metadata
- Authors
- Glover, E. I., Martin, J., Maher, A., Thornhill, R. E., Moran, G. R., & Tarnopolsky, M. A.
- Venue
- Muscle & Nerve
- Publisher
- Wiley
- Published
- 2010-09-30
- Volume
- 42
- Issue
- 5
- Pages
- 739-748
- ISSN
- 0148-639X
- 1097-4598
- Cited by
- 129
- References
- 8
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.